SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Stressgen (VSE: SSB)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
236 8 0 SSB
Emcee:  Andy Patton Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
211Protein Could Slow Degenerative Brain Diseases By Stephen Pincock LONDON (Reutnigel bates-5/30/2003
210Stressgen receives Roche milestones totaling US$4.5 million SAN DIEGO, CA, Aprnigel bates-4/30/2003
209To all, text from Post #6004499 over on stockhouse.ca: <i>SUBJECT: RE: CaHeat Shock-2/5/2003
208To all: Stressgen's immunotherapy to be used in trials by U.S. National CancHeat Shock-1/15/2003
207Just parking - biorex.hu Biorex is a young pharmaceutical research and developnigel bates-11/22/2002
206re: mechanism of action of StressGen's "CoVal" platform. "CoHeat Shock-11/12/2002
205Hi Nigel, As you know, biotech patent lawsuits are par for the course. In the Heat Shock-10/28/2002
204To all, "Stressgen Conference Call Comforts Investors" <i> ThurHeat Shock-10/28/2002
203I have no real idea, as I don't follow either company closely. Increased legnigel bates-10/23/2002
202Whats the impact on stressgene which has been disappointing latelyDavid Culver-10/22/2002
201NEW YORK--(BUSINESS WIRE)--Oct. 22, 2002--Antigenics Inc. (NASDAQ:AGEN - News) tnigel bates-10/22/2002
200To all: Stressgen announces presentation of data on the mechanism for the immunHeat Shock-10/10/2002
199To all, Stressgen announces presentation of new Phase II HspE7 data on genital wHeat Shock-10/10/2002
198To all, Stressgen mentioned in Forbes.com article concerning Roche making deals Heat Shock-9/24/2002
197To all: Stressgen, Roche and hepatitis C. Stressgen's press releases have aHeat Shock-8/15/2002
196To all: RRP Phase II enrolled. <i>Stressgen announces completion of enrolHeat Shock-8/15/2002
195Michael, Roche/Stressgen collaboration conference call notes: - CEO KorpolinskHeat Shock-6/24/2002
194Stressgen announces June 24, 2002 conference call to discuss Roche collaborationmichael_f_murphy-6/24/2002
193Stressgen Biotechnologies and Roche announce global development and marketing comichael_f_murphy-6/24/2002
192To all, 4 Stressgen abstracts from 5th Annual Conference on Vaccine Research - BHeat Shock-5/20/2002
191Thanks this look cheap to me plan to buy some more and wait for a better marett.David Culver-5/3/2002
190To all, some conference call notes: - CEO Korpolinsky said that the recent markHeat Shock-5/3/2002
189To all, a nice summary of Stressgen's status in the article below from DermHeat Shock-4/24/2002
188To all: here is the text of Post #4925031 by ender over on stockhouse.ca: <iHeat Shock-3/19/2002
187To all: conference call notes: - potential partners are especially interested tHeat Shock-2/13/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News